BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29623585)

  • 21. Abdominoperineal resection for squamous cell anal carcinoma: survival and risk factors for recurrence.
    Lefèvre JH; Corte H; Tiret E; Boccara D; Chaouat M; Touboul E; Svrcek M; Lefrancois M; Shields C; Parc Y
    Ann Surg Oncol; 2012 Dec; 19(13):4186-92. PubMed ID: 22825769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis.
    De B; Rhome R; Doucette J; Buckstein M
    Dis Esophagus; 2017 Apr; 30(4):1-10. PubMed ID: 28375481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
    Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
    Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
    Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
    Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
    Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of radiation dose on locoregional control and survival on squamous cell carcinoma of anal canal.
    Engineer R; Mallik S; Mahantshetty U; Shrivastava S
    Radiother Oncol; 2010 Jun; 95(3):283-7. PubMed ID: 20452695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Outcomes With Dose Escalation Using Modern Radiotherapy Techniques: A Retrospective Review of Anal Cancer Treated at a Large Academic Institution Between 2010 and 2016.
    Murchison SC; DeVries KJ; Atrchian S
    Cureus; 2020 Oct; 12(10):e10989. PubMed ID: 33209545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base.
    Chapman BV; Gill BS; Viswanathan AN; Balasubramani GK; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):107-117. PubMed ID: 27843030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal.
    Wright JL; Gollub MJ; Weiser MR; Saltz LB; Wong WD; Paty PB; Temple LK; Guillem JG; Minsky BD; Goodman KA
    Dis Colon Rectum; 2011 Sep; 54(9):1090-7. PubMed ID: 21825888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
    Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The results of radiotherapy for squamous cell carcinomas of the skin.
    Soydemir GP; Kandaz M; Melikoğlu M
    Dermatol Ther; 2019 Sep; 32(5):e13058. PubMed ID: 31394022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anal canal squamous cell cancer: are surgical alternatives to chemoradiation just as effective?
    Suradkar K; Pappou EE; Lee-Kong SA; Feingold DL; Kiran RP
    Int J Colorectal Dis; 2018 Feb; 33(2):181-187. PubMed ID: 29270784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.
    Dasgupta T; Rothenstein D; Chou JF; Zhang Z; Wright JL; Saltz LB; Temple LK; Paty PB; Weiser MR; Guillem JG; Nash GM; Goodman KA
    Radiother Oncol; 2013 May; 107(2):189-94. PubMed ID: 23692961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.
    Widder J; Kastenberger R; Fercher E; Schmid R; Langendijk JA; Dobrowsky W; Pötter R
    Radiother Oncol; 2008 Jun; 87(3):367-75. PubMed ID: 18501453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base.
    Geltzeiler CB; Nabavizadeh N; Kim J; Lu KC; Billingsley KG; Thomas CR; Herzig DO; Tsikitis VL
    Ann Surg Oncol; 2014 Oct; 21(11):3616-20. PubMed ID: 24943237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is survival reduced for patients with anal cancer requiring surgery after failure of radiation? Analysis from a population study over two decades.
    Kiran RP; Pokala N; Rottoli M; Fazio VW
    Am Surg; 2009 Feb; 75(2):163-8. PubMed ID: 19280811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.